AssetMark Inc’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,700
Closed -$35K 1656
2022
Q2
$35K Buy
1,700
+1,350
+386% +$24K ﹤0.01% 1015
2022
Q1
$6K Hold
350
﹤0.01% 1261
2021
Q4
$7K Sell
350
-1,725
-83% -$32.5K ﹤0.01% 1205
2021
Q3
$38K Hold
2,075
﹤0.01% 831
2021
Q2
$56K Hold
2,075
﹤0.01% 738
2021
Q1
$62K Hold
2,075
﹤0.01% 698
2020
Q4
$60K Buy
2,075
+417
+25% +$11.3K ﹤0.01% 683
2020
Q3
$40K Buy
1,658
+1,655
+55,167% +$35.7K ﹤0.01% 714
2020
Q2
$0 Buy
+3
New +$39 ﹤0.01% 1480
2020
Q1
Sell
-160
Closed -$2K 1579
2019
Q4
$2K Buy
+160
New +$1.94K ﹤0.01% 1274

Other funds holding CVET

AssetMark Inc's CVET Position: Q3 2022 in Review

AssetMark Inc sold out of Covetrus, Inc. Common Stock (CVET) in Q3 2022, closing a stake of 1,700 shares — an estimated $35K sold.

AssetMark Inc first reported a position in CVET in Q4 2019 and held it in 10 quarters. The position peaked at $62K in Q1 2021. 250 funds tracked by Wall St. Rank hold CVET as of Q3 2022.

  • AssetMark Inc reported no remaining Covetrus, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • AssetMark Inc sold 1,700 Covetrus, Inc. Common Stock shares in Q3 2022, an estimated $35K.
  • AssetMark Inc first reported a position in Covetrus, Inc. Common Stock in Q4 2019 and held it in 10 quarters.
  • AssetMark Inc's Covetrus, Inc. Common Stock position peaked at $62K in Q1 2021.
  • 250 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q3 2022.

Based on AssetMark Inc's 13F filing for Q3 2022, filed 1 Nov 2022.